Related Experiment Video
Updated: Nov 27, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
FDA Approval of Remdesivir - A Step in the Right Direction
Daniel Rubin1, Kirk Chan-Tack1, John Farley1
1From the Division of Biometrics IV, Office of Biostatistics (D.R.), the Division of Antivirals, Office of Infectious Diseases (K.C.-T.), and the Office of Infectious Diseases (J.F., A.S.), Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD.
No abstract available in PubMed .
More Related Videos
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Regulation
Bioequivalence studies: Biowaivers
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...